| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 268251 | 4,6-DIDEOXY-4-[[[(14-METHYL-1-OXOPENTADECYL)AMINO]ACETYL]AMINO]-N-1H-PURIN-6-YL-.BETA.-L-GLUCOPYRANOSYLAMINE | 0.00957309511256283 | 0.089789727 |
| NSC 370875 | Null | 0.00957309511256283 | 0.063547786 |
| NSC 629620 | Null | 0.00957309511256283 | -0.029711697 |
| NSC 656925 | Null | 0.00957309511256283 | 0.34240908 |
| NSC 664161 | Null | 0.00957309511256283 | 0.17771452 |
| NSC 669885 | Null | 0.00957309511256283 | 0.058326195 |
| NSC 672449 | Null | 0.00957309511256283 | 0.15848802 |
| NSC 676790 | Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-[4-O-(.beta.-D-xylopyranosyl)- .beta.-D-xylopyranosyl]-6-deoxy-.beta.-D-gulopyranosyl]- .beta.-L-arabinopyranos | 0.00957309511256283 | 0.016681424 |
| NSC 683856 | Null | 0.00957309511256283 | 0.27211556 |
| NSC 692655 | D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate | 0.00957309511256283 | 0.19400932 |